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Single-chain derivatives of gp120 linked to the first two
domains of CD4 (gp120-CD4D12) or to the CD4 analogue
CD4M9 were assessed for their abilities to elicit CD4-
induced neutralizing antibodies. Both complexes showed
binding to a CD4i epitope as defined by the mAb 17b.
Addition of exogenous CD4 did not increase 17b binding
to gp120-CD4D12 but augmented binding to gp120-M9
perhaps reflecting the lower binding affinity of M9 to
gp120 compared to CD4D12 or suggesting that M9 does
not completely fill the CD4 binding site of gp120. Vacci-
nation of guinea pigs and rhesus monkeys with recom-
binant protein or DNA prime followed by protein
boosting generated broadly neutralizing antibodies only
for sera generated against gp120-CD4D12. Passage of these
sera over a CD4D12 affinity column removed neutralizing
activities. Rhesus monkeys were also immunized with
gp120-human CD4 or gp120-rhesus CD4 complex. Virus-
neutralizing antisera were observed for each of these
groups, but titers were much greater for the gp120-human
CD4 complex. Neutralizing antibody titers showed a sig-
nificant correlation to CD4 antibody titer for both vaccine
groups. These data suggest that most neutralizing antibod-
ies generated by gp120-CD4 complexes are directed
against CD4.
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